- $137.44m
- $193.98m
- $70.99m
- 40
- 44
- 42
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.6 | 49.1 | 74.7 | 76.3 | 71 |
Cost of Revenue | |||||
Gross Profit | 29.3 | 41.6 | 65.5 | 67 | 62.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 137 | 136 | 141 | 132 | 93.7 |
Operating Profit | -103 | -87.2 | -66.5 | -55.9 | -22.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -110 | -99.8 | -82.3 | -74.8 | -35.5 |
Net Income After Taxes | -110 | -99.8 | -82.3 | -74.8 | -35.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -110 | -99.8 | -82.3 | -74.8 | -35.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -110 | -99.8 | -82.3 | -74.8 | -35.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.46 | -2.07 | -1.45 | -0.871 | -0.317 |